US82835W1080 - SPRY (XNAS)
SILVERBACK THERAPEUTICSCS INC Aktie
11,18 USD
Aktuelle Kurse von SILVERBACK THERAPEUTICSCS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
SPRY
|
USD
|
20.12.2024 22:01
|
11,18 USD
| 11,32 USD | -1,24 % |
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | -5,93 % | -20,14 % | -24,31 % | 36,84 % | 116,67 % | -55,28 % |
Profil de l'entreprise pour SILVERBACK THERAPEUTICSCS INC Action
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Données de l'entreprise pour SILVERBACK THERAPEUTICSCS INC Action
Nom SILVERBACK THERAPEUTICSCS INC
Société ARS Pharmaceuticals, Inc.
Symbole SPRY
Site web https://www.silverbacktx.com
Marché d'origine
NASDAQ
ISIN US82835W1080
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Capitalisation boursière 1 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Adresse 3525 Del Mar Heights Road, 92130 San Diego
Date d'introduction en bourse 2020-12-04
ID Changes
Date | From | To |
---|---|---|
09.11.2022 | SBTX | SPRY |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | SBTX |
NASDAQ | SPRY |
More Shares
Investors who SILVERBACK THERAPEUTICSCS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.